Related Experiment Video
Updated: Sep 16, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Cardiologists' Perceptions of Cardiogenetic Testing and Management
W H Wilson Tang1, Quan M Bui2, Allison L Cirino3
1Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Cardiogenetic testing is underutilized despite its clinical relevance. Improving access to genetic counselors and expanding education are key to increasing its adoption in cardiovascular care.
Area of Science:
- Cardiovascular Medicine
- Medical Genetics
- Healthcare Management
Background:
- Cardiogenetic testing is crucial for understanding and managing inherited cardiovascular diseases.
- Despite its importance, the clinical use of cardiogenetic testing remains inconsistent and suboptimal.
Purpose of the Study:
- To evaluate cardiologists' views on cardiogenetic testing.
- To identify barriers, facilitators, educational needs, and clinical applications for cardiogenetic testing.
Main Methods:
- A survey was conducted among 161 cardiologists from the American College of Cardiology CardioSurve Panel.
- Data was collected between March and April 2024.
Main Results:
- 80% of surveyed cardiologists have ordered or referred patients for cardiogenetic testing.
- Confidence in ordering tests (40%) and interpreting results (31%) was low; 40% lacked training.
- Key barriers included high costs (60%), limited genetic counselor access (59%), and low interpretation confidence (43%).
Conclusions:
- Enhanced access to genetic counselors and professionals is recommended.
- Clearer guidelines and comprehensive education are essential for increasing cardiogenetic testing adoption.
- Integration of cardiogenetic testing into routine cardiovascular care requires addressing identified barriers.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview